Weekly Low-Dose Methotrexate Therapy for Sarcoidosis

Internal Medicine

Volumn 33, Issue 7, 1994, Pages 437-440

  Suda, Takafumi ^a   Sato, Atsuhiko ^a   Toyoshima, Mikio ^a   Imokawa, Shiro ^a   Yoshitomi, Atsushi ^a   Tamura, Ryoji ^a   Suganuma, Hideki ^a   Yagi, Takeshi ^a   Hayakawa, Hiroshi ^a   Shirai, Masahiro ^a   Chida, Kingo ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

refractory sarcoidosis; steroid sparing effect

Indexed keywords

CORTICOSTEROID; GALLIUM CITRATE GA 67; METHOTREXATE;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DRUG EFFICACY; HUMAN; LUNG FUNCTION; MALE; ORAL DRUG ADMINISTRATION; SARCOIDOSIS;

ADULT; CASE REPORT; HUMAN; MALE; METHOTREXATE; SARCOIDOSIS;

EID: 0027959258     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.33.437     Document Type: Article

References (15)

1. Roenigk HH Jr, Fowler-Bergfeld W, Curtis GH. Methotrexate for psoriasis in weekly oral doses. Arch Dermatol 99: 86, 1969.
2. Kozarek RA, Patterson DJ, Gelfand MD, Botoman VA, Ball TJ, Wilske KR. Methotrexate induces clinical and histological remission in patients with refractory inflammatory bowel disease. Ann Intern Med 110: 353, 1989.
3. Kremer JM, Lee JK. A long-term prospective study of the use of methotrexate in rheumatoid arthritis. Arthritis Rheum 31: 577, 1988.
4. Mullarkey MF, Blumenstein BA, Andrade WP, et al. Methotrexate in the treatment of corticosteroid-dependent asthma. New Engl J Med 318:603, 1988.
5. Israel HL. Treatment of sarcoidosis. Thorax 20: 57, 1971.
6. Veien NK, Brodthagen H. Cutaneous sarcoidosis treated with methotrexate. Br J Dermatol 97: 213, 1977.
7. Soriano FG, Caramelli P, Nitrini R, Rocha AS. Neurosarcoidosis: therapeutic success with methotrexate. Postgrad Med J 66: 142, 1990.
8. Lower EE, Baughman RP. The use of low dose methotrexate in refractory sarcoidosis. Am J Med 299: 153, 1990.
9. Shupack JL, Webster GF. Pancytopenia following low-dose oral methotrexate therapy for psoriasis. JAMA 259: 3594, 1988.
10. Lanse SB, Arnold GL, Gowans JDC, Kaplan MM. Low incidence of hepatotoxicity associated with long-term, low-dose oral methotrexate in treatment of refractory psoriasis, psoriatic arthritis, and rheumatoid arthritis. Dig Dis Sci 30: 104, 1985.
11. Carson CW, Cannon GW, Egger MJ, Ward JR, Clegg DO. Pulmonary disease during the treatment of rheumatoid arthritis with low dose pulse methotrexate. Semin Arthritis Rheum 16: 186, 1987.
12. Weinblatt ME, Coblyn JS, Fox DA, et al. Efficacy of low-dose methotrexate in rheumatoid arthritis. N Engl J Med 312: 818, 1985.
13. Temowitz T, Bjerring P, Andersen PH, et al. Methotrexate inhibits the human C5a-induced skin response in patients with psoriasis. J Invest Dermatol 89: 192, 1987.
14. Van De Kerkhof PCM, Bauer FW, Maasen DE, et al. Methotrexate inhibits the leukotriene B4 induced intraepidermal accumulation of polymorphonuclear leukocytes. Br J Dermatol 113: 251a, 1985.
15. Baughman RP, Lower EE. The effect of corticosteroid or methotrexate therapy on lung lymphocytes and macrophages in sarcoidosis. Am Rev Respir Dis 142: 1268, 1990.